Natco Pharma Limited has informed the Exchange regarding a press release dated Jun 16, 2023, titled "NATCO receives final approval for Tipiracil Hydrochloride and Trifluridine (generic for Lonsurf��) for the US market".
Natco Pharma Limited has informed the Exchange regarding a press release dated Jun 16, 2023, titled "NATCO receives final approval for Tipiracil Hydrochloride and Trifluridine (generic for Lonsurf��) for the US market".